Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

Journal of the Pakistan Medical Association

Volumn 64, Issue 4, 2014, Pages 471-473

  Hashim, Husnain ^a   Zeb un Nisa, ^a   Alrukn, Suhail Abdulla Mohammad ^a   Madani, Abubaker Abdul Rahman Shaffi Al ^a  

^a DUBAI HEALTH AUTHORITY   (United Arab Emirates)

Author keywords

Electroconvulsive therapy; Neuroleptic Malignant Syndrome

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CREATINE KINASE; DANTROLENE; DIAZEPAM; FENTANYL; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE; PRAMIPEXOLE; PROCYCLIDINE; PROPOFOL; RISPERIDONE;

ABNORMAL BEHAVIOR; ADULT; AGGRESSION; AGITATION; ARTICLE; BLOOD PRESSURE FLUCTUATION; CASE REPORT; CONFUSION; DIET THERAPY; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FEVER; HALLUCINATION; HEART RATE; HUMAN; HYDRATION; MENTAL INSTABILITY; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; OROFACIAL DYSKINESIA; PHYSIOTHERAPY; RESTLESSNESS; VENTILATOR;

ADULT; ANTIPSYCHOTIC AGENTS; DISEASE PROGRESSION; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; TREATMENT FAILURE;

EID: 84897143566     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137-45.
2. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77: 185-202.
3. Keck PE Jr, Pope HG Jr, Cohen BM, McElroy SL, Nierenberg AA. Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry 1989; 46: 914-8.
4. Woodbury MM, Woodbury MA. Neuroleptic-induced catatonia as a stage in theprogressiontowardneurolepticmalignantsyndrome. J Am Acad Child Adolesc Psychiatry 1992; 31: 1161-4.
5. Adam Wysokinski: Intensive Electroconvulsive Therapy In Drug Resistant Neurolepticmalignant Syndrome - Case Report Psychiatria Danubina, 2012; 24: 219-22.
6. Yousefi A, Asgari F. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome: a case report. Tehran Uni Med J 2010; 67: 817-20.
7. Scheftner WA, Shulman RB. Treatment choice in neuroleptic malignant syndrome. Convuls Ther 1992; 8: 267-79.
8. Trollor JN, Sachdev PS. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry. 1999; 33: 650-9.
9. Tadke RR, Suryavanshi P. Use of intravenous valproate in a patient with neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci 2006; 18: 131-2.